![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
A more recent version of this article appeared on December 1, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 10, 2006
Revised on September 18, 2006
Accepted on September 26, 2006
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110
Monitoring Editor: Sean Munro
Cryptococcus neoformans, which causes fatal infection in immunocompromised individuals, has an elaborate polysaccharide capsule surrounding its cell wall. The cryptococcal capsule is the major virulence factor of this fungal organism, but its biosynthetic pathways are virtually unknown. Extracellular polysaccharides of eukaryotes may be made at the cell membrane or within the secretory pathway. To test these possibilities for cryptococcal capsule synthesis, we generated a secretion mutant in C. neoformans by mutating a Sec4/Rab8 GTPase homolog. At a restrictive temperature, the mutant displayed reduced growth and protein secretion, and accumulated 
100 nm vesicles in a polarized manner. These vesicles were not endocytic, as shown by their continued accumulation in the absence of polymerized actin, and could be labeled with anti-capsular antibodies as visualized by immuno-electron microscopy. These results indicate that glucuronoxylomannan, the major cryptococcal capsule polysaccharide, is trafficked within post-Golgi secretory vesicles. This strongly supports the conclusion that cryptococcal capsule is synthesized intracellularly and secreted via exocytosis.
This article has been cited by other articles:
|
|
 |
|
  M. L. Rodrigues, M. Alvarez, F. L. Fonseca, and A. Casadevall Binding of the Wheat Germ Lectin to Cryptococcus neoformans Suggests an Association of Chitinlike Structures with Yeast Budding and Capsular Glucuronoxylomannan Eukaryot. Cell, April 1, 2008; 7(4): 602 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yoneda and T. L. Doering Regulation of Cryptococcus neoformans Capsule Size Is Mediated at the Polymer Level Eukaryot. Cell, March 1, 2008; 7(3): 546 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Rodrigues, E. S. Nakayasu, D. L. Oliveira, L. Nimrichter, J. D. Nosanchuk, I. C. Almeida, and A. Casadevall Extracellular Vesicles Produced by Cryptococcus neoformans Contain Protein Components Associated with Virulence Eukaryot. Cell, January 1, 2008; 7(1): 58 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Nimrichter, S. Frases, L. P. Cinelli, N. B. Viana, A. Nakouzi, L. R. Travassos, A. Casadevall, and M. L. Rodrigues Self-Aggregation of Cryptococcus neoformans Capsular Glucuronoxylomannan Is Dependent on Divalent Cations Eukaryot. Cell, August 1, 2007; 6(8): 1400 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. McFadden, B. C. Fries, F. Wang, and A. Casadevall Capsule Structural Heterogeneity and Antigenic Variation in Cryptococcus neoformans Eukaryot. Cell, August 1, 2007; 6(8): 1464 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Cottrell, C. L. Griffith, H. Liu, A. A. Nenninger, and T. L. Doering The Pathogenic Fungus Cryptococcus neoformans Expresses Two Functional GDP-Mannose Transporters with Distinct Expression Patterns and Roles in Capsule Synthesis Eukaryot. Cell, May 1, 2007; 6(5): 776 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Liu, M. J. S. Kelly, E. D. Chow, and H. D. Madhani Parallel {beta}-Helix Proteins Required for Accurate Capsule Polysaccharide Synthesis and Virulence in the Yeast Cryptococcus neoformans Eukaryot. Cell, April 1, 2007; 6(4): 630 - 640. [Abstract] [Full Text] [PDF]
|
|
